Skip to main content

Table 3 Thrombogram parameters and Pd-MP levels in all patients and in patients on chemotherapy according to the time since the diagnosis (less than 6 months or more)

From: Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

 

All patients (n = 62)

Patients on chemotherapy (n = 41)

 

0-6 months (n = 27)

>6 months (n = 35)

0-6 months (n = 20)

>6 months (n = 21)

MRI (nM/min)

160 ± 60*

153 ± 48

161 ± 55*

148 ± 52

Peak (nM)

353 ± 92*

336 ± 70*

362 ± 73*

324 ± 74

ETP (nM.min)

1593 ± 340*

1483 ± 332

1627 ± 335*

1402 ± 327

Pd-MP (/μL)

10098 ± 7057

9946 ± 9175

10054 ± 7769

9026 ± 7469

Pd-MP/PS + (/μL)

9731 ± 6821

9671 ± 8841

9695 ± 7488

8793 ± 7265

PPL (sec)

43,9 ± 10,8

43,3 ± 10,1

43,3 ± 12,3

44,7 ± 10,8

  1. Values are mean ± sd. *p < 0,05 versus >6 months.